Elizabeth A. Olek, Senior VP, CLINICAL SCIENCE at Kronos Bio, Inc. (KRON), sold 7,368 shares at $1.05 ($8K) on 2024-02-21, disclosed to the SEC on 2024-02-23.
Open-market sale of $8k KRON by Senior VP, CLINICAL SCIENCE. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |